Global Multiplex Biomarker Imaging Market (2018-2023)

The multiplex biomarker imaging market will grow because of its ability to detect the presence of, severity, and exact location of chronic diseases and tumors, along with other applications. According to Netscribes, the global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018-2023 period, generating a revenue of USD 523.59 Mn by 2023.

The global multiplex biomarker imaging market can be segmented based on:

o Techniques - immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), immunofluorescence (IF), tissue microarray (TMA), and toponome imaging system (TIS)
o Components - instruments, reagents and kits, and software
o Applications - oncology studies, drug safety, genetic characterization, and others (neurodegeneration and protein research)
o End users - research institutes, translational labs, and pharma and biopharma companies

Technique segment insights:

IHC held the largest market share (around 47%) in this segment in 2017. It is widely used in research laboratories and clinical diagnostics, owing to the advantages it offers, vis-à-vis traditional methods of enzyme staining, including specific antigen-antibody reactions. Higher incidence of chronic diseases, especially cancer, is fuelling the need for targeted treatments, thereby contributing to the growth of TMA. The market for TMA is projected to expand at a CAGR of 14.3% during the 2018-2023 period.
Component segment insights:

The instruments section held the largest market share (67%) in 2017, followed by reagents and kits. However, software is predicted to record the fastest expansion (CAGR of 15.0%) during the forecast period (2018-2023), with more automated software packages being made available to researchers. These software modules assist in the research of various diseases and improve the workflow of quantitative analysis.

Application segment insights:

Multiplex biomarker imaging products are used mostly in oncology studies. This will be followed by drug safety applications, which is expected to expand at a CAGR of 14.1% during 2018-2023.

End user segment insights:

Currently, multiplex biomarker imaging products can only be used for research purposes. Pharma and biopharma companies dominated the market's end user segment in 2017 with a share of 39%. Meanwhile, translational laboratories are projected to grow at a significant rate during the forecast period.

Regional insights:

The global multiplex biomarker imaging market can be segmented based on regions into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America dominated the global multiplex biomarker imaging market with a share of 50% in 2017, followed by Europe with a 28% share. Asia-Pacific is expected to expand at the highest CAGR (16.0%) during 2018-2023. Across North America and Europe, companies that have software and service agreements for several years are directly selling imaging products to biopharmaceutical companies, laboratories, and academic institutions.

Companies covered:

o Thermo Fisher Scientific, Inc.
o Perkin Elmer, Inc.
o Abcam Plc.
o Bio-Rad Laboratories Inc.
o US Biomax, Inc.
o Merck KGaA
o Ventana Medical Systems, Inc.
o MicroConstants, Inc.
o Leica Biosystems Nussloch GmbH
o ToposNomos Ltd.
o Illumina, Inc.



Chapter 1. Executive summary

1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2: Global multiplex biomarker imaging market - overview

2.1. Global market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), geography-wise market revenue (USD Mn), and market attractiveness analysis
2.2. Global market drivers
2.3. Global market challenges
2.4. Global market trends
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
2.8. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
2.9. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
2.10. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 3: North America multiplex biomarker imaging market

3.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
3.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
3.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
3.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
3.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 4: Europe multiplex biomarker imaging market

4.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
4.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
4.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
4.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
4.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 5: Asia-Pacific multiplex biomarker imaging market

5.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
5.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
5.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
5.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
5.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 6: Latin America multiplex biomarker imaging market

6.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
6.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
6.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
6.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
6.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 7: The Middle East and Africa multiplex biomarker imaging market

7.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
7.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
7.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
7.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
7.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 8: Competitive landscape

8.1. Thermo Fisher Scientific, Inc.
8.1.a. Company snapshot
8.1.b. Product offerings
8.1.c. Growth strategies
8.1.d. Initiatives
8.1.e. Geographical presence
8.1.f. Key numbers
8.2. Perkin Elmer, Inc.
8.2.a. Company snapshot
8.2.b. Product offerings
8.2.c. Growth strategies
8.2.d. Initiatives
8.2.e. Geographical presence
8.2.f. Key numbers
8.3. Abcam Plc.
8.3.a. Company snapshot
8.3.b. Product offerings
8.3.c. Growth strategies
8.3.d. Initiatives
8.3.e. Geographical presence
8.3.f. Key numbers
8.4. Bio-Rad Laboratories Inc.
8.4.a. Company snapshot
8.4.b. Product offerings
8.4.c. Growth strategies
8.4.d. Initiatives
8.4.e. Geographical presence
8.4.f. Key numbers
8.5. U.S. Biomax, Inc.
8.5.a. Company snapshot
8.5.b. Product offerings
8.5.c. Growth strategies
8.5.d. Initiatives
8.5.e. Geographical presence
8.5.f. Key numbers
8.6. Merck KGaA
8.6.a. Company snapshot
8.6.b. Product offerings
8.6.c. Growth strategies
8.6.d. Initiatives
8.6.e. Geographical presence
8.6.f. Key numbers
8.7. Ventana Medical Systems, Inc.
8.7.a. Company snapshot
8.7.b. Product offerings
8.7.c. Growth strategies
8.7.d. Initiatives
8.7.e. Geographical presence
8.7.f. Key numbers
8.8. MicroConstants, Inc.
8.8.a. Company snapshot
8.8.b. Product offerings
8.8.c. Growth strategies
8.8.d. Initiatives
8.8.e. Geographical presence
8.8.f. Key numbers
8.9. Leica Biosystems Nussloch GmbH
8.9.a. Company snapshot
8.9.b. Product offerings
8.9.c. Growth strategies
8.9.d. Initiatives
8.9.e. Geographical presence
8.9.f. Key numbers
8.10. ToposNomos Ltd.
8.10.a. Company snapshot
8.10.b. Product offerings
8.10.c. Growth strategies
8.10.d. Initiatives
8.10.e. Geographical presence
8.10.f. Key numbers
8.11. Illumina, Inc.
8.11.a. Company snapshot
8.11.b. Product offerings
8.11.c. Growth strategies
8.11.d. Initiatives
8.11.e. Geographical presence
8.11.f. Key numbers

Chapter 9: Conclusion
9.1. Future Outlook

Appendix
o List of tables
o Research methodology
o Assumptions
o About Netscribes, Inc.



Global Biomarker Deals Market Research Report 2019

Published Date : Feb 2019

Biomarker Deals Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, German...

Global Medical Imaging Instrumentation Market Research Report 2019

Published Date : Feb 2019

Medical Imaging Instrumentation Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Unite...

Global Surgical Imaging Devices Market Research Report 2019

Published Date : Feb 2019

Surgical Imaging Devices Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United State...

Global Fluorescence Lifetime Imaging Microscopy Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Fluorescence-lifetime imaging microscopy or FLIM is an imaging technique for producing an image based on the differences in the exponential decay rate of the fluorescence from a fluorescent sample. It can be used as an imaging technique in confocal microscopy, two-photon excitation microscopy, and m...

Global Thermal Imaging Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Thermal imaging is a method of improving visibility of objects in a dark environment by detecting the objects' infrared radiation and creating an image based on that information. Scope of the Report: The global average price of thermal imaging is in the decreasing trend, from 17.0...

Global Medical Imaging Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Medical imaging refers to several different technologies that are used to view the human body in order to diagnose, monitor, or treat medical conditions. Each type of technology gives different information about the area of the body being studied or treated, related to possible disease, injury, or t...

Global Breast Imaging Equipment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Breast Imaging Equipment is an equipment using low-energy X-rays (usually around 30 kVp) to examine the women's breast, and it is used as a diagnostic and screening tool. Breast Imaging Equipment is for the early detection of breast cancer, typically through characteristic masses' detection. ...

Global Breast Imaging Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Breast Imaging is an equipment to examine the women's breast, and it is used as a diagnostic and screening tool. Breast Imaging Equipment is for the early detection of breast cancer, typically through characteristic masses' detection. Scope of the Report: In the last several years...

Global Diagnostic X-Ray Imaging Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Diagnostic imaging equipment is primarily used for imaging the human body with the help of various imaging technologies. These devices are used to monitor, diagnose, screen, and treat various medical conditions for effective medical intervention. It has also improved the ability of doctors to treat,...

Global Veterinary Diagnostic Imaging Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Veterinary diagnostic imaging equipment is primarily used for imaging the animal body with the help of various imaging technologies. Diagnostic imaging is the noninvasive method of making medical images of the body to diagnose disease. Scope of the Report: In the last...

 

Select License :

  • Single User : $3999

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.